drugset / Trial / NCT00984295

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

NCT00984295

Phase 3 Completed 1913 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupOpen-labelPrevention

Summary

This study will assess the safety and immunogenicity of ProQuad when administered concomitantly and nonconcomitantly with Tripedia and Comvax.

Timeline

Start
2000-06
Primary completion
2001-10
Completion
2001-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Adacel Vaccine 0.5 ml Intramuscular
Subject Comvax Vaccine 0.5 ml Intramuscular
Comparator M-M-R II Vaccine 0.5 ml Subcutaneous
Subject Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live Vaccine 0.5 ml Subcutaneous
Comparator Varivax Vaccine 0.5 ml Subcutaneous